Physician profile
Jacob Blake
NPI 1154486769
$7,522.01
in general payments reported to CMS, 2019-2025
25 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,412 · 2020: $133 · 2021: $404 · 2022: $1,451 · 2023: $1,425 · 2024: $1,643 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,121.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,480.79 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Relievant Medsystems, INC. | $1,138.58 | 2021-2023 | Intracept |
| Vertiflex, INC. | $1,003.55 | 2019 | |
| Saluda Medical Americas, INC. | $483.83 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic, INC. | $242.72 | 2023-2024 | Mazor X System, Unid_pass, Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $214.67 | 2019-2021 | |
| Nevro Corp. | $174.01 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $124.74 | 2024-2025 | Sprint Pns System |
| Abbvie INC. | $112.74 | 2021-2024 | Botox, Ubrelvy |
| Vertos Medical, INC. | $112.45 | 2021 | |
| Abbott Laboratories | $101.89 | 2020-2024 | Eterna, Proclaim |
| Allergan, INC. | $71.82 | 2019-2021 | |
| Globus Medical, INC. | $31.89 | 2025 | Senza |
| Pfizer INC. | $30.49 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $24.77 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $22.81 | 2019 | |
| Assertio Therapeutics, INC. | $22.43 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $19.55 | 2021 | |
| Scilex Pharmaceuticals INC. | $18.48 | 2024 | |
| Medtronic USA, INC. | $16.31 | 2019 | |
| Tersera Therapeutics LLC | $15.81 | 2021 | |
| Upsher-Smith Laboratories LLC | $15.53 | 2023 | |
| Lilly USA, LLC | $15.42 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.03 | 2019 | |
| Mdd US Operations, LLC | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.